Group 1 - The issuance of the 2025 first phase technology innovation bond by Tianjin Jiuan Medical Electronics Co., Ltd. marks a significant milestone as it is the first technology innovation bond for private technology enterprises in Tianjin, with a total issuance scale of 1.05 billion yuan [1] - The bond issuance is a key initiative by Industrial Bank Tianjin Branch to support the development of private technology enterprises, aligning with the central financial work conference's spirit and promoting financial resources towards "early, small, long-term, and hard technology" sectors [1][3] - The funds raised from the bond will be primarily allocated to upgrading smart medical devices and building a digital platform for chronic disease management, enhancing the company's technological leadership in the industry [2] Group 2 - Jiuan Medical has established a strong foundation for the bond issuance through its commitment to technological innovation, with a dedicated R&D team and significant investment in research, resulting in multiple national patents and industry awards [2] - The company's iHealth series of smart medical devices integrates mobile internet technology with precise detection functions, covering various health monitoring scenarios and achieving a market presence in over 100 countries [2] - The company has developed an innovative "O+O" model for diabetes management, providing comprehensive services from screening to long-term health management, having served over 500,000 chronic disease patients [2]